Taiwan FDA registration 6264101a4950f6e5f64a1c2c919224c6

Hallywood bone joint injection

TW: 瀚樂骨關節腔注射液

Taiwan·Risk Class 3·LG Chem, Ltd.·Registered Sep 21, 2010 – Sep 21, 2025Expired

Registration details

Analysis ID: 6264101a4950f6e5f64a1c2c919224c6
Customs Code: DHA00602148004

Company information

Manufacturer: LG Chem, Ltd.
Manufacturer Country: Korea, Republic of
Authorized Representative: HOLLING BIO-PHARMA. CORP.

Product details

Intended Use: Treatment of patients with degenerative knee arthritis pain is limited to conservative non-pharmacological treatment and when general analgesics (Acetaminophen) are ineffective. The following blanks. Efficacy change: Limited to patients with degenerative knee arthritis and shoulder arthritis pain who do not respond to conservative non-drug treatment and general analgesics (such as Acetaminophen). (The original approved version of 101.3.12 Chinese copy of the copy shall be invalidated). The following blanks.
Product Type (Level 1): N Orthopedics
Import Information: import

Dates and status

Registration Date: Sep 21, 2010
Expiry Date: Sep 21, 2025

About this record

Access comprehensive regulatory information for Hallywood bone joint injection in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 6264101a4950f6e5f64a1c2c919224c6 and manufactured by LG Chem, Ltd.. The authorized representative in Taiwan is HOLLING BIO-PHARMA. CORP..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.